Auro Laboratories Limited (AUROLAB.BO)
INR 246.3
(-0.5%)
INR 246.3
(-0.5%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 433.09 Million INR | 98.73% |
| 2022 | 217.93 Million INR | -7.02% |
| 2021 | 234.39 Million INR | 76.1% |
| 2020 | 133.1 Million INR | 22.67% |
| 2019 | 108.5 Million INR | -32.41% |
| 2018 | 160.53 Million INR | -7.88% |
| 2017 | 174.25 Million INR | 0.2% |
| 2016 | 173.91 Million INR | 1.88% |
| 2015 | 170.7 Million INR | -19.02% |
| 2014 | 210.79 Million INR | 5.71% |
| 2013 | 199.41 Million INR | -15.13% |
| 2012 | 234.97 Million INR | 11.07% |
| 2011 | 211.54 Million INR | 24.59% |
| 2010 | 169.79 Million INR | 27.21% |
| 2009 | 133.47 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 433.09 Million INR | 98.73% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 433.09 Million INR | 0.0% |
| 2023 Q2 | 246.94 Million INR | 0.0% |
| 2022 FY | 217.93 Million INR | -7.02% |
| 2022 Q4 | 217.93 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 205.57 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 234.39 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 174.65 Million INR | 0.0% |
| 2021 FY | 234.39 Million INR | 76.1% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 133.1 Million INR | 0.0% |
| 2020 Q2 | 124.72 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 133.1 Million INR | 22.67% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 108.5 Million INR | -32.41% |
| 2019 Q2 | 111.7 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 108.5 Million INR | 0.0% |
| 2018 Q2 | 189.92 Million INR | 0.0% |
| 2018 Q4 | 160.53 Million INR | 0.0% |
| 2018 FY | 160.53 Million INR | -7.88% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 174.25 Million INR | 0.0% |
| 2017 FY | 174.25 Million INR | 0.2% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 185.36 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 173.91 Million INR | 1.88% |
| 2016 Q4 | 173.91 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 149.81 Million INR | 0.0% |
| 2015 Q4 | 170.7 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 198.76 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 170.7 Million INR | -19.02% |
| 2014 Q4 | 210.79 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 215.41 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 210.79 Million INR | 5.71% |
| 2013 Q1 | 202.02 Million INR | -14.02% |
| 2013 FY | 199.41 Million INR | -15.13% |
| 2013 Q2 | 200.81 Million INR | -0.6% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q4 | 199.41 Million INR | 0.0% |
| 2012 Q3 | 226.98 Million INR | 0.0% |
| 2012 FY | 234.97 Million INR | 11.07% |
| 2012 Q4 | 234.97 Million INR | 3.52% |
| 2011 Q4 | 211.54 Million INR | 0.0% |
| 2011 FY | 211.54 Million INR | 24.59% |
| 2010 FY | 169.79 Million INR | 27.21% |
| 2010 Q4 | 169.79 Million INR | 0.0% |
| 2009 FY | 133.47 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -1585.132% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 71.138% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 56.532% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -1963.349% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -707.309% |
| Sunil Healthcare Limited | 902.83 Million INR | 52.029% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -20252.303% |
| MedPlus Health Services Limited | 14.27 Billion INR | 96.966% |
| Zenith Healthcare Limited | 24.03 Million INR | -1701.943% |
| Patidar Buildcon Limited | 25.57 Million INR | -1593.638% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -179.3% |
| Roopa Industries Limited | 493.08 Million INR | 12.166% |
| Smruthi Organics Limited | 485.72 Million INR | 10.834% |
| Trident Lifeline Limited | 331.26 Million INR | -30.742% |
| Bacil Pharma Limited | 1.12 Million INR | -38261.116% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -107.779% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -167.883% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 56.877% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -266.339% |
| PANJON LTD. | 25.38 Million INR | -1606.248% |
| Tyche Industries Limited | 101.64 Million INR | -326.105% |
| Trimurthi Limited | 101.36 Thousand INR | -427185.912% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -2791.361% |
| Anuh Pharma Limited | 1.54 Billion INR | 71.961% |
| Crestchem Limited | 23.94 Million INR | -1708.565% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -3130.862% |
| Zenlabs Ethica Limited | 301.35 Million INR | -43.717% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -48.588% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 73.935% |
| Parmax Pharma Limited | 117.56 Million INR | -268.381% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 76.731% |
| Deccan Health Care Limited | 111.33 Million INR | -289.0% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -114.432% |
| Norris Medicines Limited | 278.17 Million INR | -55.693% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 74.735% |
| Veerhealth Care Limited | 62.78 Million INR | -589.865% |
| Makers Laboratories Limited | 569.18 Million INR | 23.909% |
| Lactose (India) Limited | 536.39 Million INR | 19.258% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 48.017% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 61.703% |
| Mercury Laboratories Limited | 171.18 Million INR | -152.993% |
| Gennex Laboratories Limited | 535.21 Million INR | 19.079% |
| PRAVEG LIMITED | 767.53 Million INR | 43.573% |
| Denis Chem Lab Limited | 289.82 Million INR | -49.436% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 74.765% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -114.838% |
| Colinz Laboratories Limited | 24.1 Million INR | -1696.71% |
| Godavari Drugs Limited | 957.86 Million INR | 54.785% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -144748.495% |
| Zenotech Laboratories Limited | 156.64 Million INR | -176.478% |
| Panchsheel Organics Limited | 340.2 Million INR | -27.306% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 11.317% |
| Vivanza Biosciences Limited | 148.63 Million INR | -191.391% |
| Phaarmasia Limited | 211.49 Million INR | -104.779% |
| Bharat Parenterals Limited | 2.65 Billion INR | 83.697% |
| Medi-Caps Limited | 63.01 Million INR | -587.281% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -267.889% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -119.431% |
| BDH Industries Limited | 312.53 Million INR | -38.576% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -147.248% |
| Coral Laboratories Limited | 281.83 Million INR | -53.668% |
| Concord Drugs Limited | 249.88 Million INR | -73.318% |
| Beryl Drugs Limited | 85.63 Million INR | -405.742% |
| Evoq Remedies Limited | 116.23 Million INR | -272.614% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -172.039% |
| Transchem Limited | 6.72 Million INR | -6344.896% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -4781.616% |
| Parnax Lab Limited | 1.17 Billion INR | 63.006% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -931.871% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 59.051% |
| Cian Healthcare Limited | 1.03 Billion INR | 58.129% |
| Trinity League India Limited | 876 Thousand INR | -49340.297% |
| Syschem (India) Limited | 1.07 Billion INR | 59.551% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 78.801% |
| Natural Capsules Limited | 1.47 Billion INR | 70.681% |